Blog Entry List
This bulletin replaces the NC Medicaid Respiratory Syncytial Virus (RSV) Guidelines for 2023-2024 - Revised published Nov. 3, 2023.
How to best serve beneficiaries who have not received nursing services for 30 consecutive days.
How to create an association in Sandata allowing providers to work with their clients
NC Medicaid will update the PADP fee schedule effective Feb. 1, 2024.
Beginning Jan. 28, 2024, five new additional exclusion sanction questions will be added.
The American Medical Association has added new CPT codes, deleted others and changed the descriptions of some existing codes.
Effective with date of service Aug. 15, 2023, the NC Medicaid programs cover elranatamab-bcmm injection, for subcutaneous use (Elrexfio).
Effective with date of service Sept. 1, 2023, NC Medicaid covers talquetamab-tgvs injection, for subcutaneous use (Talvey).
Effective with date of service Sept. 6, 2023, NC Medicaid Direct and NC Medicaid Managed Care cover avacincaptad pegol intravitreal solution (Izervay)
Effective with date of service Sept. 1, 2023, NC Medicaid Direct and NC Medicaid Managed Care cover cantharidin topical solution (Ycanth).
Effective with date of service Aug. 21, 2023, Medicaid covers aflibercept injection, for intravitreal use (Eylea HD)
Effective with date of service Aug. 19, 2023, NC Medicaid covers pozelimab-bbfg injection, for intravenous or subcutaneous use (Veopoz).
The updated policy aims to minimize the impact of health plan accreditation on delegated care management entities
Flexibilities in the approved amendment will be effective March 1, 2024, and considered ongoing
North Carolina Medicaid will reimburse pharmacies for utilizing the statewide Self-Administered Hormonal Contraceptive Protocol for pharmacists.